Kwesi Teye Selected Research

Kwesi Teye Research Topics

Disease

16	Pemphigus (Pemphigus Vulgaris) 02/2023 - 05/2013
8	Skin Diseases (Skin Disease) 02/2023 - 05/2013
6	Bullous Pemphigoid (Pemphigoid) 01/2023 - 04/2016
4	Blister (Bulla) 01/2023 - 02/2013
2	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 02/2023 - 05/2013
2	Inflammation (Inflammations) 01/2023 - 08/2015
2	Atopic Dermatitis (Atopic Eczema) 02/2021 - 05/2017
2	Starvation 01/2016 - 05/2010
2	Carcinogenesis 01/2016 - 05/2005
2	Benign Familial Pemphigus (Hailey Hailey Disease) 07/2014 - 02/2013
2	Erythema 01/2014 - 05/2013
2	Neoplasms (Cancer) 11/2004 - 01/2004
1	Monoclonal Gammopathy of Undetermined Significance 02/2023
1	Multiple Myeloma 02/2023
1	Disease Progression 02/2023
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2023
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2023
1	Pathologic Complete Response 12/2019
1	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 05/2017
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Bronchiolitis Obliterans 02/2016
1	Linear IgA Bullous Dermatosis 09/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2013
1	Hyperkeratosis of the palms and soles and esophageal papillomas 02/2013
1	Darier Disease (Darier's Disease) 02/2013
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 02/2013
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 02/2013
1	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 02/2013
1	Epidermolytic Palmoplantar Keratoderma 02/2013
1	Naxos disease 02/2013
1	Lymphoma (Lymphomas) 10/2007
1	Colonic Neoplasms (Colon Cancer) 10/2007
1	Esophageal Squamous Cell Carcinoma 10/2007
1	Body Weight (Weight, Body) 12/2002
1	Leukemia 09/2002

Drug/Important Bio-Agent (IBA)

13	AntibodiesIBA 01/2021 - 05/2013
10	AutoantibodiesIBA 02/2023 - 07/2013
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
8	DesmocollinsIBA 01/2021 - 05/2013
7	Immunoglobulin A (IgA)IBA 02/2023 - 05/2013
7	Immunoglobulin G (IgG)IBA 01/2021 - 07/2013
5	AntigensIBA 01/2017 - 05/2013
5	AutoantigensIBA 08/2016 - 10/2013
4	DesmogleinsIBA 01/2021 - 10/2013
4	EnzymesIBA 01/2018 - 05/2010
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2004
3	ImmunosorbentsIBA 01/2018 - 08/2016
2	Filaggrin ProteinsIBA 02/2021 - 05/2017
2	EpitopesIBA 01/2021 - 04/2016
2	CalciumIBA 01/2021 - 02/2013
2	Monoclonal AntibodiesIBA 01/2017 - 10/2007
2	Immunoglobulins (Immunoglobulin)IBA 08/2016 - 04/2016
2	Desmoglein 3IBA 04/2016 - 03/2014
2	Messenger RNA (mRNA)IBA 07/2014 - 09/2002
2	Desmoglein 1IBA 03/2014 - 01/2014
1	Interleukin-9 (Interleukin 9)IBA 01/2023
1	Edetic Acid (EDTA)FDA Link 01/2021
1	Immunoglobulin M (IgM)IBA 01/2017
1	envoplakinIBA 08/2016
1	Recombinant ProteinsIBA 04/2016
1	epiplakinIBA 02/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	early endosome antigen 1IBA 01/2016
1	IntegrinsIBA 09/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2015
1	Indicators and Reagents (Reagents)IBA 08/2015
1	shikoninIBA 08/2015
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 03/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015
1	Adenosine Triphosphatases (ATPase)IBA 07/2014
1	Collagen Type VIIIBA 03/2014
1	KalininIBA 03/2014
1	Rituximab (Mabthera)FDA Link 07/2013
1	Cadherins (E-Cadherin)IBA 07/2013
1	Prednisolone (Predate)FDA LinkGeneric 05/2013
1	PlakophilinsIBA 02/2013
1	Keratins (Keratin)IBA 02/2013
1	Succinic Acid (Succinate)IBA 05/2010
1	Ribosomal RNAIBA 05/2010
1	Histones (Histone)IBA 05/2010
1	Ribosomal DNA (rDNA)IBA 05/2010
1	LDL CholesterolIBA 12/2002
1	CholesterolIBA 12/2002
1	oxidized low density lipoproteinIBA 12/2002
1	HDL CholesterolIBA 12/2002
1	phorbolIBA 09/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2019